Originally published byEU-Startups
Imperagen, a Manchester-based BioTech company using AI and quantum physics to engineer better enzymes faster, has closed €5.7 million (£5 million) in Seed funding to accelerate R&D, expand its wet lab capabilities, and build out its go-to-market function over the next 18 months. The round was led by PXN Ventures with participation from Imperagen’s existing […]
The post Manchester Imperagen raises €5.8 million Seed to scale AI and quantum-powered enzyme engineering appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
Europe’s AI future depends on UK-France-Germany DARPA alliance, says Nobel winner
16h ago
Earlybird raising €500m defence fund with French investor AVP, sources say
3h ago
Paris-based Prelude raises €17.2 million Series A to scale its onboarding and trust infrastructure platform
1d ago
London’s Searchable raises €11.9 million at €72.1 million valuation to help brands boost visibility across AI-led search
12h ago
Could Europe’s Red Tape finally be its Biggest Moat?
2d ago